Recent studies indicate that popular weight-loss drugs, such as Ozempic and Wegovy, might play a role in treating or preventing certain cancers. This finding adds to the list of unexpected benefits linked to GLP-1s. Currently, one in eight American adults uses these medications.
William Brangham provides more details on this development. Brangham is a recognized correspondent and producer for PBS News Hour and also hosts Horizons from PBS.
Joe Biden’s Battle with Prostate Cancer: A Deeper Look 
Rising Cases of Vibrio Vulnificus Infections in Louisiana and Florida 
Ethan Suplee’s Approach to Weight Loss and Sobriety 
MaineHealth to Close Lincoln Hospital Maternity Unit Despite Community Opposition 
A Personal Journey with Cancer: Strength, Family, and Hope 
Coping With Cancer: A Personal Journey